Huikwang Past Earnings Performance

Past criteria checks 1/6

Huikwang's earnings have been declining at an average annual rate of -7.8%, while the Chemicals industry saw earnings growing at 7.5% annually. Revenues have been declining at an average rate of 3.1% per year. Huikwang's return on equity is 4.2%, and it has net margins of 6.6%.

Key information

-7.8%

Earnings growth rate

-8.2%

EPS growth rate

Chemicals Industry Growth7.9%
Revenue growth rate-3.1%
Return on equity4.2%
Net Margin6.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Huikwang (GTSM:6508) Might Have The Makings Of A Multi-Bagger

Mar 31
Huikwang (GTSM:6508) Might Have The Makings Of A Multi-Bagger

Huikwang Corporation (GTSM:6508) Is Yielding 5.9% - But Is It A Buy?

Mar 10
Huikwang Corporation (GTSM:6508) Is Yielding 5.9% - But Is It A Buy?

Huikwang (GTSM:6508) Could Easily Take On More Debt

Feb 16
Huikwang (GTSM:6508) Could Easily Take On More Debt

Is Huikwang Corporation's (GTSM:6508) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 27
Is Huikwang Corporation's (GTSM:6508) Latest Stock Performance Being Led By Its Strong Fundamentals?

Shareholders Of Huikwang (GTSM:6508) Must Be Happy With Their 65% Return

Jan 06
Shareholders Of Huikwang (GTSM:6508) Must Be Happy With Their 65% Return

Will the Promising Trends At Huikwang (GTSM:6508) Continue?

Dec 15
Will the Promising Trends At Huikwang (GTSM:6508) Continue?

Is Huikwang Corporation (GTSM:6508) A Smart Choice For Dividend Investors?

Nov 27
Is Huikwang Corporation (GTSM:6508) A Smart Choice For Dividend Investors?

Revenue & Expenses Breakdown

How Huikwang makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:6508 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,54310322337
31 Mar 241,4909721937
31 Dec 231,5279121938
30 Sep 231,56310723037
30 Jun 231,94218726138
31 Mar 232,32826028036
31 Dec 222,49131428136
30 Sep 222,73635727637
30 Jun 222,42726924036
31 Mar 222,19636325636
31 Dec 212,08932927135
30 Sep 211,88429726335
30 Jun 211,78329725534
31 Mar 211,76215721635
31 Dec 201,83718920937
30 Sep 201,87420321538
30 Jun 202,00422923240
31 Mar 202,08324824942
31 Dec 192,07722624441
30 Sep 192,21824425640
30 Jun 192,16622125139
31 Mar 192,20422326136
31 Dec 182,16918225735
30 Sep 182,06816024234
30 Jun 182,12217224233
31 Mar 182,01613723433
31 Dec 172,07313724928
30 Sep 172,15515527223
30 Jun 172,21213929418
31 Mar 172,37714431613
31 Dec 162,29916931513
30 Sep 162,26614730714
30 Jun 162,19316028714
31 Mar 162,18416926714
31 Dec 152,32416527114
30 Sep 152,47419128813
30 Jun 152,53319827514
31 Mar 152,70221529114
31 Dec 142,70424028914
30 Sep 142,6502332809
30 Jun 142,6262182909
31 Mar 142,44019627210
31 Dec 132,37716926112

Quality Earnings: 6508 has high quality earnings.

Growing Profit Margin: 6508's current net profit margins (6.6%) are lower than last year (9.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6508's earnings have declined by 7.8% per year over the past 5 years.

Accelerating Growth: 6508's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6508 had negative earnings growth (-45.2%) over the past year, making it difficult to compare to the Chemicals industry average (13.7%).


Return on Equity

High ROE: 6508's Return on Equity (4.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies